C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1992
12/23/1992	WO1992022657A1 Antigen-enzyme conjugate expression and detection system
12/23/1992	WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	WO1992022655A1 Hepatitis c diagnostics and vaccines
12/23/1992	WO1992022653A1 Method for making humanized antibodies
12/23/1992	WO1992022652A1 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM
12/23/1992	WO1992022651A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	WO1992022646A1 Production of human hemoglobin in transgenic pigs
12/23/1992	WO1992022645A1 Transgenic immunodeficient non-human animals
12/23/1992	WO1992022644A1 Production of a protein of interest in the milk of a transgenic mammelian
12/23/1992	WO1992022641A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	WO1992022640A1 Rb TRANSFERRED CELLS AND METHOD
12/23/1992	WO1992022638A1 Perilipin
12/23/1992	WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins
12/23/1992	WO1992022581A1 Cold tolerances in plants
12/23/1992	WO1992022579A1 MIMIC PEPTIDES OF gp120
12/23/1992	WO1992022578A1 Novel polypeptides and their use
12/23/1992	WO1992022577A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
12/23/1992	WO1992022576A1 Crf analogs
12/23/1992	WO1992022575A1 M-protein peptides of influenza virus as antiviral agents
12/23/1992	WO1992022574A1 Medicinal use of jacaline and fragments thereof, in particular for treating hiv-related diseases
12/23/1992	WO1992022573A1 Detection of mammalian immunodeficiency viruses
12/23/1992	WO1992022572A1 New hiv-1 gag and env peptides, diagnostic
12/23/1992	WO1992022570A1 Inhibitors of picornavirus proteases
12/23/1992	WO1992022568A1 Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
12/23/1992	WO1992022567A1 Super glucocorticoid receptors: receptors with increased affinity and specificity for glucocorticoid steroids
12/23/1992	WO1992022332A2 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
12/23/1992	WO1992022329A1 USE OF β-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES
12/23/1992	WO1992022328A1 USE OF β-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
12/23/1992	WO1992022327A1 Double recombinant vaccinia virus vaccines
12/23/1992	WO1992022326A1 Insertional mutations in mycobacteria
12/23/1992	WO1992022325A1 Vaccine for and method of treating parasitic hemoflagellate protozoa
12/23/1992	WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992	WO1992022322A1 Lhrh analogs
12/23/1992	WO1992022320A1 C1 inhibitor variants and treating inflammatory response with c1 inhibitor
12/23/1992	WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF
12/23/1992	WO1992022317A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	WO1992022316A1 Biological regulation of mineralization
12/23/1992	WO1992022315A1 Synthetic pulmonary surfactant peptides
12/23/1992	WO1992022314A1 Purified chitinases and use thereof
12/23/1992	WO1992022303A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/23/1992	WO1992022207A1 Biological control
12/23/1992	WO1992017588A3 Method for production of an iga binding protein derived from group b streptococci
12/23/1992	WO1992017200A3 Stable growth hormone metal ion formulations
12/23/1992	WO1992016612A3 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
12/23/1992	WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g
12/23/1992	EP0519903A1 Drug containing activated protein C
12/23/1992	EP0519900A1 Pharmaceutical preparation containing a thrombolytically active substance and Protein C
12/23/1992	EP0519889A2 Leydig cell stimulator
12/23/1992	EP0519869A2 A receptor protein kinase gene encoded at the self-incompatibility locus
12/23/1992	EP0519866A1 Novel anti-HIV antibodies
12/23/1992	EP0519829A1 Cloning and/or expressionvectors, preparation and use
12/23/1992	EP0519750A2 Insulin analogs
12/23/1992	EP0519728A2 Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies
12/23/1992	EP0519726A2 A process for large-scale production of antimicrobial peptide in high purity
12/23/1992	EP0519640A1 Rapid synthesis and screening of peptide mimetics
12/23/1992	EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
12/23/1992	EP0519547A2 Coccidiosis poultry vaccine
12/23/1992	EP0519469A1 Cloned glutamic acid decarboxylase
12/23/1992	EP0519354A1 A prophylactic/therapeutic composition containing WS7622A for preventing or treating disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
12/23/1992	EP0519336A2 Chimeric gene comprising a promoter-regulater and a gene coding for an indicator protein
12/23/1992	EP0519327A1 N-Acyl-S-(2-hydroxyalkyl)-cysteines, their preparation and their use as intermediates in the preparation of synthetic immunoadjuvants and synthetic vaccines
12/23/1992	EP0519218A2 Hybrid-plasmid for the 38 kDa antigen from M. tuberculosis, E. coli as host, the 38 kDa antigen and a 33 kDa protein
12/23/1992	EP0519039A1 HUMAN bFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION
12/23/1992	EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt
12/23/1992	EP0519011A1 Protein expression via seed specific regulatory sequences
12/23/1992	EP0519008A1 Interleukin-4 binding proteins
12/23/1992	EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/23/1992	EP0518999A1 Protein hydrolysates.
12/23/1992	EP0518982A1 Method for enhancing antibody transport through capillary barriers
12/23/1992	EP0518933A1 Leukaemia inhibitory factor
12/23/1992	EP0262192B1 Method and means for producing a protein having the same igg specificity as protein g
12/23/1992	CA2277721A1 Cold tolerances in plants
12/23/1992	CA2111681A1 Mimic peptides of gp120
12/23/1992	CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	CA2111584A1 Use of b-cell tropin (acth 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases
12/23/1992	CA2111583A1 Use of b-cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases
12/23/1992	CA2111472A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	CA2111471A1 Inhibitors of picornavirus proteases
12/23/1992	CA2111456A1 Recombinant immunogenic actinomycetale
12/23/1992	CA2111348A1 Production of human hemoglobin in transgenic pigs
12/23/1992	CA2111342A1 Synthetic pulmonary surfactant peptides
12/23/1992	CA2111217A1 Insertional mutations in mycobacteria
12/23/1992	CA2111214A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	CA2111110A1 Production and recovery of recombinant neurotrophins
12/23/1992	CA2111108A1 Hepatitis c diagnostics and vaccines
12/23/1992	CA2110901A1 Crf analogs
12/23/1992	CA2110489A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992	CA2108263A1 M-protein peptides of influenza virus as antiviral agents
12/23/1992	CA2103377A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/22/1992	US5173427 Hepatitus B core Antigen; immunoassay; DNA sequence altered to include additional nucleotides between the ribosome binding site and start or initiator codon
12/22/1992	US5173426 Pure polynucleotide; for increasing tissue oxygenation in patients
12/22/1992	US5173425 Transforming host cell with DNA sequence that encodes two ferredoxin polypeptides for each reductase polypeptide and iron-sulfur polypeptide by growing transformed organisms in the presence of iron
12/22/1992	US5173422 Monoclonal antibodies specific for human glycoalbumin
12/22/1992	US5173419 Purified chitinases and use thereof
12/22/1992	US5173414 Production of recombinant adeno-associated virus vectors
12/22/1992	US5173409 Recovery of bt endotoxin protein from lysed cell mixtures
12/22/1992	US5173404 Quantitative analysis; monitoring reproductive functions
12/22/1992	US5173400 Antibody detection of antibodies to viral proteins in serum
12/22/1992	US5173297 Bacteriocin from lactococcus lactis subspecies lactis

1 ... 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 ... 2916